Company: MGLD
Filing Date: 2025-09-19
Form Type: 10-K
Source: 0001493152-25-014286
Chunk: 773

Company: Marygold Companies, Inc.
Filing Date: 2025-09-19
Form: 10-K
Item: Item 7
Chunk 773
---
 721,160 shares of common stock. There are 13,302
and 49,360
shares of Series B Convertible Preferred Stock outstanding as of June 30, 2025 and 2024, respectively.

Stock-based
Compensation

In
2021, the Company adopted the 2021 Omnibus Equity Incentive Plan (“Equity Plan”) which provides for the grant of stock-based
awards, including stock options, restricted stock awards (“RSAs”) and restricted stock units (“RSUs”), to employees
and non-employees. A total of 5,000,000 shares of common stock are authorized for issuance under the Plan, of which 3,772,485 are available
for future grants as of June 30, 2025.

The
fair value of stock options is estimated on the date of grant using the Black-Scholes option pricing model and recognized as compensation
on a straight-line basis between the date of grant and the date the options become fully vested. Stock options issued have a term of
ten years. The fair value of the options granted were estimated using the following assumptions:

 SCHEDULE OF SHARE BASED COMPENSATION

    Year Ended June 30, 

    2025  
    2024 
  
    Expected volatility 
     137% 
     165%
  
    Expected term 
     6.1 years  
     6.1 years 
  
    Risk-free interest rate 
     4.5% 
     4.2%
  
    Expected dividend yield 
     0% 
     0%

The
fair value of RSAs is estimated on the grant date based on the closing quoted market price of the Company’s stock and the RSAs
generally vest over a four-year period following issuance date, subject to continued service. The fair value of RSAs is recognized
as compensation on a straight-line basis between the date of grant and the date the RSAs become fully vested.

During
fiscal 2025 and 2024, the following activity occurred under the Company’s Equity Plan.

 SCHEDULE OF SHARE BASED COMPENSATION STOCK OPTIONS

    Stock Options  
    Restricted Stock 

    Number of Shares  
    Weighted Average
                                                                                Exercise Price  
    Number of Shares  
    Weighted
Average
                                                                                                  Grant Date
Fair Value 
  
    Balance at June 30, 2023 
     270,000